MIROCALS: Modifying Immune Response and OutComes in ALS

Clinical trial NCT03039673 · COMPLETED

Trial details

NCT number: NCT03039673
Sponsor: Centre Hospitalier Universitaire de Nīmes
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-06-19
Primary completion: 2021-07-22
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.